vimarsana.com

Page 19 - ஐரோப்பிய ஆரோக்கியம் தொழிற்சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Europe s vaccine rollout to take centre stage at online summit of EU leaders

Europe’s vaccine rollout to take centre stage at online summit of EU leaders Thursday and Friday s European Council meeting will see leaders discuss the EU’s response to the ongoing pandemic and the vaccination rollout strategy. Fotolia 24 Feb 2021 The current rollout of Coronavirus vaccines in Europe is way behind that of several nations such as the UK, the US and Israel. On Thursday, Parliament s environment and industry committees will meet with the leaders of various pharmaceutical companies to debate ways of how to increase vaccine production and improve delivery. Ahead of that meeting, Dutch member Esther de Lange, the EPP group vice chairwoman responsible for economy and environment, said, “Nothing we can do is more costly than the human and economic cost of this pandemic. We must act faster and think bigger.”

Sassoli says rethink of economic governance instruments will be important factors in EU s economic recovery

A high-profile panel on Monday (22 February) warned of the economic difficulties stemming from the pandemic, whilst noting that this crisis could offer the chance to rebuild EU economies. Kicking off the annual European Parliamentary Week, which sees MEPs and national parliamentarians meet to discuss EU economic governance, the panel brought together the presidents of […]

Europe s post-pandemic strategy for the WHO – European Council on Foreign Relations

Covid-19 has shown, to our distracted and fast-changing world, the essential role of the World Health Organization (WHO) in the survival of humanity, and the value of solidarity and cooperation. In 2020 then US president Donald Trump suspended contributions to the WHO, accusing it of collusion with the Chinese government. The decision shocked the international community – mainly because it came at a time when almost all states recognised the need for efficient global multilateral governance. The WHO’s work on the treatment of diseases worldwide requires not only a great deal of effort, competence, and time but also large amounts of money and autonomy. It is certainly true that the WHO is slowed by organisational deficiencies and bureaucracy but, regardless, it is counterproductive to reduce contributions to its budget. The WHO receives funding from two main sources – contributions from its 194 member states (calculated as a percentage of their GDP), and voluntary contributions

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.